Galanin is a 29/30 amino acids long neuropeptide which does not belong
to any known peptide family. The N-terminal first 16 amino acids of t
he molecule are both necessary and sufficient for receptor recognition
and receptor activation, The main pharmacophores of galanin in its ce
ntral and pancreatic actions are Gly(1), Trp(2), Asn(5) and Tyr(9), re
spectively. The neuropeptide galanin has multiple effects in both the
central and peripheral nervous systems. Centrally, galanin potently st
imulates fat intake and impairs cognitive performance. Anoxic glutamat
e release in the hippocampus is inhibited by galanin and the noradrene
rgic tonus in the brain is influenced by a hyperpolarizing action of g
alanin in the locus coeruleus. In the spinal cord galanin inhibits spi
nal excitability and potentiates the analgesic effect of morphine. In
the neuroendocrine system galanin acts in a stimulatory manner on the
release of growth hormone and prolactin, and peripherally galanin inhi
bits glucose induced insulin release. Galanin also causes contraction
of the jejunum. The galanin receptor is a G(i)-protein-coupled, membra
ne-bound glycoprotein with an estimated molecular mass of 53 kDa. Seve
ral putative tissue specific galanin receptor subtypes have been propo
sed on a pharmacological basis. The distribution of galanin receptors
and of galanin like immunoreactivity are overlapping in the CNS, both
being high in areas such as the locus coeruleus, raphe nucleus and hyp
othalamus. Galanin receptor activation leads to a reduced intracellula
r Ca2+-concentration, either by direct action on voltage sensitive Ca2
+-channels or indirectly via opening of K+-channels or via inhibition
of adenylyl cyclase activity. The lowered intracellular Ca2+ level sub
sequently leads to a reduced PLC activity. Galanin also inhibits cGMP
synthesis induced by depolarization. A number of synthetic high affini
ty galanin receptor antagonists of the peptide type were developed rec
ently, which have enabled the elucidation of functional roles of endog
enous galanin in several systems. Furthermore, putative subtypes of ga
lanin receptors can be distinguished by the use of these new galanin r
eceptor ligands.